Biomarkers Through The Development, Progression and Chronic Complications of Diabetes Mellitus: A Mini-Review

Journal Title: Journal of Endocrinology and Diabetes - Year 2018, Vol 5, Issue 6

Abstract

Biomarkers are widely known to be elevated in patients with obesity, diabetes and related chronic complications such as nephropathy, retinopathy and cardiovascular disease. Obesity epidemic has resulted in an increased risk of diabetes development and consequent cardiovascular mortality, leading to probing the usefulness of the inflammatory biomarkers triggered by adipose tissue in individuals at risk. However, current knowledge regarding the clinical usefulness of inflammatory markers in individuals progressing from one stage to another is inconclusive. Therefore, the purpose of this review is to provide an insight on the clinical utility of temporary relationships of biomarker elevations at specific stages of type 2 diabetes. Recently it has been proposed that increased levels of low-grade inflammation biomarkers such as EN-RAGE and IL-13, may serve as indicators for risk of progression from normoglycemia to pre-diabetes and from pre-diabetes to diabetes, respectively. In the development of chronic complications of type 2 diabetes, biomarkers such as TNF-alpha have been proposed to serve as markers of incident albuminuria. Cardiac biomarkers may serve as feasible predictors of the risk of cardiovascular outcomes in diabetic patients. Furthermore, relationships amongst specific biomarkers have been proposed to function as possible future instruments of detection of T2DM such as IL-6, CRP and insulin. Clinicians may be benefited from biomarker profiles on the progression of the disease, minimizing economic and social repercussions.

Authors and Affiliations

David E. Garcia, Maddy Narváez-Méndez, Samantha Morgan, Martín Coronado-Malagón, César Alejandro Arce-Salinas, Antonio Baraja, Isabel Arenas, Alejandro Svarch

Keywords

Related Articles

Non-classical Congenital Adrenal Hyperplasia: the challenge of an accurate diagnosis

We present the case of a 24 year-old lady with mild congenital adrenal hyperplasia (CAH) who presented with infertility, hirsutism and clitoromeglay and increased 17 alpha hydroxy progesterone serum levels. She was treat...

Social Representations of Feeding People with Type-2 Diabetes Mellitus

The aim of this study was to analyze the social representations of the diets 34 patients of the Brazilian public primary care service diagnosed with type- 2 diabetes mellitus, according to how they represent their identi...

The Possible Role of New Basal Insulin Analogues in Pediatric Population

In the pediatric age HbA1c values below 7.5% represent the ideal metabolic and glicemic target in DMT1 patients, but the literature shows that many of them are still very far from reaching this goal. The introduction of...

Outcome of Patients with Diabetic Ketoacidosis in South of Iran

Introduction: Diabetic Keto acidosis (DKA) is the most common cause of mortality in children with diabetes mellitus. The aim of this study is to investigate the complications of DKA and its complications in hospitalized...

Circulating Lipocalin-2 Levels Are Associated With Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels In Type 2 Diabetic Patients

Purpose: Diabetes mellitus is associated with atherosclerotic and cardiovascular diseases. Our aim was to investigate the levels of lipocalin-2 (LCN-2) and soluble Lectin-like oxidized low-density lipoprotein receptor-1(...

Download PDF file
  • EP ID EP427568
  • DOI 10.15226/2374-6890/5/6/001121
  • Views 107
  • Downloads 0

How To Cite

David E. Garcia, Maddy Narváez-Méndez, Samantha Morgan, Martín Coronado-Malagón, César Alejandro Arce-Salinas, Antonio Baraja, Isabel Arenas, Alejandro Svarch (2018). Biomarkers Through The Development, Progression and Chronic Complications of Diabetes Mellitus: A Mini-Review. Journal of Endocrinology and Diabetes, 5(6), 1-7. https://europub.co.uk/articles/-A-427568